Medical Countermeasures

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Medical Countermeasures trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (4 shown)

CompletedPhase 1

NCT06741345

Phase 1 BIO 300 Oral Suspension

This is a two-part study of BIO 300 Oral Suspension in healthy male and female volunteers. The first part is a multiple ascending dose (MAD) study to test the s…

United States56 participantsStarted 2024-12-23

Treatment: BIO 300 Oral Suspension

Active — Not RecruitingPhase 4

NCT05300477

Pharmacological Countermeasures for High Altitude

The aim of this randomized, double-blind study is to determine whether erythropoietin (Procrit) and acetazolamide: 1) mitigates altitude-induced decrements in p…

United States18 participantsStarted 2022-05-27

Treatment: Acetazolamide, Erythropoietin

TerminatedPhase 1

NCT04314713

A Study to Evaluate the Intramuscular Administration of Scopolamine

To characterize the safety and tolerability profile of ascending doses of scopolamine hydrobromide trihydrate (Scopolamine HBT) administered by intramuscular (I…

United States32 participantsStarted 2020-06-02

Treatment: Scopolamine Hydrobromide Trihydrate

CompletedPhase 1/2

NCT02363322

Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection

Background: \- Ebola is a viral infection that can spread quickly and causes life-threatening disease. Right now there is an Ebola outbreak in many countries i…

United States, Guinea +2 more72 participantsStarted 2015-03-13

Treatment: B/Current Standard of Care Plus ZMapp, A/Current Standard of Care Alone